Skip to content

Public FDA record

Z-1809-2020: Philips Azurion 7 M20 -XperGuide Software hosted in Interventional Workspot 1.5 when used with the Azuri

Recall record Z-1809-2020 for Philips North America, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1809-2020
Company in FDA record
Philips North America, LLC
FDA classification date
Apr 29, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

When a user acquires XperCT scan on an Azurion 2.0 system, enters the XperGuide guidance step and moves the L-arm away from the initial scan position before starting the live guidance, a warning message directs the user to move the L-arm stand back to the initial XperCT scan position. Although the software generates this message, it does not prevent the use of live guidance if the L-arm stand is not repositioned. Using live guidance with a mispositioned L-arm can result in the display of an incorrect overlay and needle path.

Source facts

Action
Philips Healthcare issued Urgent Medical Device Correction letter via Field Action 2020-IGTBST-003 issued on April 3, 2020. Letter states reason for recall, health risk an action to take: To avoid this hazardous situation, the users should: BY CUSTOMER/ USER " Use XperGuide live guidance with the L-arm positioned in the XperCT scan position. " Move the L-arm back to the initial XperCT scan position if the system displays the warning Live 3D roadmap not possible. Please move stand to the : [acquisition position] position. At any stage during needle guidance, the user can perform a verification run to verify if the needle position is correct. Please ensure that all staff working with the XperGuide application are informed of the content of this letter and place a copy of this letter as an addendum to the Instructions for Use. Questions contact your local Philips representative. Technical Support Line: 1-800-722-9377. Philips will resolve the problem for all affected systems by installing a new Interventional Workspot software release. This action will start in April 2020. Expanded Recall 12-22-20: The two systems for the Netherland have already been corrected through the implementation of software update. For the system in Germany, the Customer has been notified through the Field Safety Notice.
Initiated
2020-04-03
Root cause
Software design
Terminated
2023-02-01
Distribution
Worldwide distribution. US states of FL, ID, IL, IN, MA, and OH, Canada, Australia, Austria, Belgium, Germany, and Netherlands New Zealand, South Africa, Switzerland, Thailand
Recall number
Z-1809-2020
Recall status
Terminated
CDRH record ID
180745
FDA classified
2020-04-29
Recall event number
85399

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗